These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 15121489)

  • 1. Low level of dopaminergic D2 receptor binding in obsessive-compulsive disorder.
    Denys D; van der Wee N; Janssen J; De Geus F; Westenberg HG
    Biol Psychiatry; 2004 May; 55(10):1041-5. PubMed ID: 15121489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced striatal dopamine D2/3 receptor availability in Body Dysmorphic Disorder.
    Vulink NC; Planting RS; Figee M; Booij J; Denys D
    Eur Neuropsychopharmacol; 2016 Feb; 26(2):350-356. PubMed ID: 26711686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine D1 receptor binding in the striatum of patients with obsessive-compulsive disorder.
    Olver JS; O'Keefe G; Jones GR; Burrows GD; Tochon-Danguy HJ; Ackermann U; Scott A; Norman TR
    J Affect Disord; 2009 Apr; 114(1-3):321-6. PubMed ID: 18706700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Striatal dopamine D(2) receptor availability in OCD with and without comorbid social anxiety disorder: preliminary findings.
    Schneier FR; Martinez D; Abi-Dargham A; Zea-Ponce Y; Simpson HB; Liebowitz MR; Laruelle M
    Depress Anxiety; 2008; 25(1):1-7. PubMed ID: 17252580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine transporter density of basal ganglia assessed with [123I]IPT SPET in obsessive-compulsive disorder.
    Kim CH; Koo MS; Cheon KA; Ryu YH; Lee JD; Lee HS
    Eur J Nucl Med Mol Imaging; 2003 Dec; 30(12):1637-43. PubMed ID: 14513291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced dopamine transporter density in psychotropic-naive patients with obsessive-compulsive disorder shown by [123I]{beta}-CIT SPECT.
    van der Wee NJ; Stevens H; Hardeman JA; Mandl RC; Denys DA; van Megen HJ; Kahn RS; Westenberg HM
    Am J Psychiatry; 2004 Dec; 161(12):2201-6. PubMed ID: 15569890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopaminergic activity in Tourette syndrome and obsessive-compulsive disorder.
    Denys D; de Vries F; Cath D; Figee M; Vulink N; Veltman DJ; van der Doef TF; Boellaard R; Westenberg H; van Balkom A; Lammertsma AA; van Berckel BN
    Eur Neuropsychopharmacol; 2013 Nov; 23(11):1423-31. PubMed ID: 23876376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alteration of dopamine D2/D3 receptor binding in patients with juvenile myoclonic epilepsy.
    Landvogt C; Buchholz HG; Bernedo V; Schreckenberger M; Werhahn KJ
    Epilepsia; 2010 Sep; 51(9):1699-706. PubMed ID: 20384765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine transporter density in the basal ganglia in obsessive-compulsive disorder, measured with [123I]IPT SPECT before and after treatment with serotonin reuptake inhibitors.
    Kim CH; Cheon KA; Koo MS; Ryu YH; Lee JD; Chang JW; Lee HS
    Neuropsychobiology; 2007; 55(3-4):156-62. PubMed ID: 17657168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patients with obsessive-compulsive disorder have increased 5-HT2A receptor binding in the caudate nuclei.
    Adams KH; Hansen ES; Pinborg LH; Hasselbalch SG; Svarer C; Holm S; Bolwig TG; Knudsen GM
    Int J Neuropsychopharmacol; 2005 Sep; 8(3):391-401. PubMed ID: 15801987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single photon emission computed tomography scan study of striatal dopamine D2 receptor binding with 123I-epidepride in patients with schizophrenia and controls.
    Tibbo P; Silverstone PH; McEwan AJ; Scott J; Joshua A; Golberg K
    J Psychiatry Neurosci; 1997 Jan; 22(1):39-45. PubMed ID: 9002391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [123]IBZM binding predicts dopaminergic responsiveness in patients with parkinsonism and previous dopaminomimetic therapy.
    Schwarz J; Tatsch K; Gasser T; Arnold G; Oertel WH
    Mov Disord; 1997 Nov; 12(6):898-902. PubMed ID: 9399212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caudate nucleus abnormalities in obsessive-compulsive disorder: measurements of MRI signal intensity.
    Calabrese G; Colombo C; Bonfanti A; Scotti G; Scarone S
    Psychiatry Res; 1993 Jun; 50(2):89-92. PubMed ID: 8378491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine D(1) receptor binding in the anterior cingulate cortex of patients with obsessive-compulsive disorder.
    Olver JS; O'Keefe G; Jones GR; Burrows GD; Tochon-Danguy HJ; Ackermann U; Scott AM; Norman TR
    Psychiatry Res; 2010 Jul; 183(1):85-8. PubMed ID: 20538439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Striatal dopaminergic D(2) receptor density measured by [(123)I]iodobenzamide SPECT in the prediction of treatment outcome of alcohol-dependent patients.
    Guardia J; Catafau AM; Batlle F; Martín JC; Segura L; Gonzalvo B; Prat G; Carrió I; Casas M
    Am J Psychiatry; 2000 Jan; 157(1):127-9. PubMed ID: 10618027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New advances in neuroimaging in the diagnosis of obsessive-compulsive disorder].
    López-Ibor Alcocer MI; Ortiz Alonso T; Encinas Mejías M; Fernández A; Maestú F; López-Ibor Aliño JJ
    Actas Esp Psiquiatr; 2000; 28(5):304-10. PubMed ID: 11269909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo PET study of 5HT(2A) serotonin and D(2) dopamine dysfunction in drug-naive obsessive-compulsive disorder.
    Perani D; Garibotto V; Gorini A; Moresco RM; Henin M; Panzacchi A; Matarrese M; Carpinelli A; Bellodi L; Fazio F
    Neuroimage; 2008 Aug; 42(1):306-14. PubMed ID: 18511303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deep brain stimulation induces striatal dopamine release in obsessive-compulsive disorder.
    Figee M; de Koning P; Klaassen S; Vulink N; Mantione M; van den Munckhof P; Schuurman R; van Wingen G; van Amelsvoort T; Booij J; Denys D
    Biol Psychiatry; 2014 Apr; 75(8):647-52. PubMed ID: 23938318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional analysis of D2 dopamine receptors in Parkinson's disease using SPECT and iodine-123-iodobenzamide.
    Nadeau SE; Couch MW; Devane CL; Shukla SS
    J Nucl Med; 1995 Mar; 36(3):384-93. PubMed ID: 7884499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normal caudate nucleus in obsessive-compulsive disorder assessed by quantitative neuroimaging.
    Aylward EH; Harris GJ; Hoehn-Saric R; Barta PE; Machlin SR; Pearlson GD
    Arch Gen Psychiatry; 1996 Jul; 53(7):577-84. PubMed ID: 8660124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.